Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  American Journal of Physiology

• Publication date

  1997-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1152/AJPGI.1997.273.2.G559PMID 9277438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preservation of intestine protein by peptide YY during total parenteral nutrition.

  1996cited by this paper
• Beneficial effects of insulin-like growth factor I on epithelial structure and function in parenterally fed rat jejunum.

  1996cited by this paper
• Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

  1996cited by this paper
• GH and IGF-I differentially increase protein synthesis in skeletal muscle and jejunum of parenterally fed rats.

  1996cited by this paper
• Effects of growth hormone and insulin-like growth factor 1 (IGF-1) treatments on the nitrogen metabolism and hepatic IGF-1-messenger RNA expression in postoperative parenterally fed rats.

  1996cited by this paper
• Parenteral nutrition is associated with intestinal morphologic and functional changes in humans.

  1995cited by this paper
• Parenteral nutrition associated with increased infection rate in children with cancer

  1993cited by this paper
• Glutamine and the preservation of gut integrity.

  1993cited by this paper
• Intravenous administration of nucleosides and a nucleotide mixture diminishes intestinal mucosal atrophy induced by total parenteral nutrition.

  1993cited by this paper
• Nutrient-independent increases in proglucagon and ornithine decarboxylase messenger RNAs after jejunoileal resection.

  1992cited by this paper
• Total parenteral nutrition: iatrogenic immunosuppression.

  1992cited by this paper
• Glucagon 1‐21 reduces intestinal epithelial cell proliferation in parenterally fed rats

  1991cited by this paper
• Ileal glucagon gene expression: ontogeny and response to massive small bowel resection.

  1990cited by this paper
• Plasma enteroglucagon, peptide YY and gastrin in rats deprived of luminal nutrition, and after urogastrone-EGF administration. A proliferative role for PYY in the intestinal epithelium?

  1989cited by this paper
• Neurotensin stimulates growth of small intestine in rats.

  1988cited by this paper
• Trophic effect of glucagon-(1-21)-peptide on the isolated rat ileal mucosal cells.

  1988cited by this paper
• Combined effects of glutamine and epidermal growth factor on the rat intestine.

  1988cited by this paper
• Total parenteral nutrition promotes bacterial translocation from the gut.

  1988cited by this paper
• Acivicin reduces tumor growth during total parenteral nutrition (TPN).

  1987cited by this paper
• Gut hormones in adaptation.

  1987cited by this paper
• Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing.

  1986cited by this paper
• Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas.

  1986cited by this paper
• Total parenteral nutrition and cancer clinical trials

  1986cited by this paper
• The Effect of Parenteral Nutrition on Gastrointestinal Immunity: The Importance of Enteral Stimulation

  1985cited by this paper
• The hormonal pattern of intestinal adaptation. A major role for enteroglucagon.

  1982cited by this paper
• Response of plasma and tissue levels of enteroglucagon immunoreactivity to intestinal resection, lactation and hyperphagia.

  1981cited by this paper
• Cholecystokinin and secretin prevent the intestinal mucosal hypoplasia of total parenteral nutrition in the dog.

  1978cited by this paper
• Small intestinal mass of the rat is partially determined by indirect effects of intraluminal nutrition.

  1976cited by this paper
• Structural and hormonal alterations in the gastrointestinal tract of parenterally fed rats.

  1975cited by this paper
• Determination of protein: a modification of the Lowry method that gives a linear photometric response.

  1972cited by this paper
• An enteroglucagon tumour

  1972cited by this paper
• Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function 1

  1971cited by this paper
• Observations on the chemical determination of deoxyribonucleic acid in animal tissues.

  1961cited by this paper

• Glucagon receptor family in GtoPdb v.2025.3

  2025cites this paper
• Low-digestible glucans promote rapid recovery from 5-fluorouracil-induced small intestinal villous atrophy while enhancing glucagon-like peptide-2 secretion in rats.

  2025cites this paper
• Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure.

  2023cites this paper
• Acute Low-intensity Treadmill Running Induces Intestinal Glucose Transporters via GLP-2 in Mice

  2021cites this paper
• Glucagon receptor family in GtoPdb v.2021.3

  2021influential citation
• Acute Low-Intensity Treadmill Running Upregulates the Expression of Intestinal Glucose Transporters via GLP-2 in Mice

  2021cites this paper
• Title : The Enteric Nervous System and Its Emerging Role as A Therapeutic Target Abbreviated Title : The ENS as an emerging therapeutic target

  2020cites this paper
• Why Recycling Matters: Glucagon-Like Peptide-2 and the Regulation of Intestinal Sodium and Fluid Absorption

  2020cites this paper
• The Enteric Nervous System and Its Emerging Role as a Therapeutic Target

  2020cites this paper
• Short Bowel Syndrome

  2019cites this paper
• Glucagon receptor family (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019influential citation
• Glucagon-like peptide-2 rescues memory impairments and neuropathological changes in a mouse model of dementia induced by the intracerebroventricular administration of streptozotocin

  2019cites this paper
• Glucagon-like Peptide-2 and the Regulation of Intestinal Growth and Function.

  2018cites this paper
• Loss of MYO5B Leads to Reductions in Na+ Absorption With Maintenance of CFTR-Dependent Cl- Secretion in Enterocytes.

  2018cites this paper
• Purified PEGylated human glucagon-like peptide-2 reduces the severity of irradiation-induced acute radiation enteritis in rats

  2018cites this paper
• Nutrient digestibility, organ morphometry and performance in vaccinated or non-vaccinated Lawsonia intracellularis infected piglets

  2018cites this paper
• Gastrointestinal functionality in animal nutrition and health: New opportunities for sustainable animal production

  2017cites this paper
• Interdependency of EGF and GLP-2 Signaling in Attenuating Mucosal Atrophy in a Mouse Model of Parenteral Nutrition

  2017influential citation
• Glucagon-Like Peptide 2 Improves Cholestasis in Parenteral Nutrition--Associated Liver Disease.

  2016cites this paper
• Influence of glucagon-like peptide 2 on energy homeostasis.

  2016cites this paper
• Ghrelin improves intestinal mucosal atrophy during parenteral nutrition: An experimental study.

  2016cites this paper
• Glucagon-Like Peptide-2 Alters Bile Acid Metabolism in Parenteral Nutrition--Associated Liver Disease.

  2016cites this paper
• GLP-2 Prevents Intestinal Mucosal Atrophy and Improves Tissue Antioxidant Capacity in a Mouse Model of Total Parenteral Nutrition

  2016cites this paper
• Nutrition in Burns

  2015cites this paper
• Characterization of Adaptive Hyperplasia of the Intestines Following Roux-En-Y Gastric Bypass and Vertical Sleeve Gastrectomy in Rats

  2015cites this paper
• When to Initialize Enteral Nutrition in Patients With Severe Acute Pancreatitis?: A Retrospective Review in a Single Institution Experience (2003–2013)

  2015cites this paper
• Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2.

  2014cites this paper
• Purified PEGylated porcine glucagon-like peptide-2 reduces the severity of colonic injury in a murine model of experimental colitis.

  2014cites this paper
• pigs by suppressing proteolysis and apoptosis GLP-2 stimulates intestinal growth in premature TPN-fed

  2013cites this paper
• Review article: a comparison of glucagon‐like peptides 1 and 2

  2013cites this paper
• GLP-2 and mesenteric blood flow.

  2013cites this paper
• Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine

  2012cites this paper
• Postconditioning with glucagon like peptide-2 reduces ischemia/reperfusion injury in isolated rat hearts: role of survival kinases and mitochondrial KATP channels

  2012cites this paper
• Glucagon-like peptide-2（GLP-2）と小腸の消化・吸収

  2011cites this paper
• Does glucagon like peptide-2 receptor expression have any effect on the development of human colorectal cancer?

  2011cites this paper
• The Role of the GLP-2 Receptor in Intestinal and Islet Adaptation to Changes in Nutrient Availability

  2011cites this paper
• Induction of Intestinal Multidrug Resistance-Associated Protein 2 by Glucagon-Like Peptide 2 in the Rat

  2010cites this paper
• Total Enteral Nutrition in Prevention of Pancreatic Necrotic Infection in Severe Acute Pancreatitis

  2010cites this paper
• The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes

  2010cites this paper
• The effect of glucagon-like peptide 2 injection on performance, small intestinal morphology, and nutrient transporter expression of stressed broiler chickens.

  2010cites this paper
• Biological actions of glucagon-like peptide(GLP)-2 revealed--how pluripotential is the glucagon gene?

  2009cites this paper
• Effect of Corticosterone Administration on Small Intestinal Weight and Expression of Small Intestinal Nutrient Transporter mRNA of Broiler Chickens

  2009cites this paper
• The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat.

  2008cites this paper
• Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats.

  2008cites this paper
• Life in the crypt: a role for glucagon-like peptide-2?

  2008cites this paper
• Glucagon-like peptide-2 activates beta-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I.

  2008cites this paper
• Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats.

  2008cites this paper
• GLP-2 Administration Results in Increased Proliferation but Paradoxically an Adverse Outcome in a Juvenile Piglet Model of Short Bowel Syndrome

  2008cites this paper
• Glucagon-Like Peptide-2 Activates β-Catenin Signaling in the Mouse Intestinal Crypt: Role of Insulin-Like Growth Factor-I

  2008cites this paper
• Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat.

  2007cites this paper
• The Role of the Gastrointestinal Hormones Ghrelin, Peptide YY, and Glucagon-like Peptide-1 in the Regulation of Energy Balance

  2007cites this paper
• Loss of exocrine pancreatic stimulation during parenteral feeding suppresses digestive enzyme expression and induces Hsp70 expression.

  2007cites this paper
• Review article: glucagon‐like peptide 2 – current applications and future directions

  2007cites this paper
• Einfluss von intravenösem Glucagon-like Peptide 2 (GLP-2) auf die Entleerungsgeschwindigkeit des Magens beim Menschen

  2007influential citation
• Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the rat.

  2007cites this paper
• Synergistic effect of supplemental enteral nutrients and exogenous glucagon-like peptide 2 on intestinal adaptation in a rat model of short bowel syndrome.

  2006cites this paper
• Glucagon-like peptide-2 acutely increases proximal small intestinal blood flow in TPN-fed neonatal piglets.

  2006cites this paper
• The role of polyamines in glucagon-like peptide-2 prevention of TPN-induced gut hypoplasia.

  2006cites this paper
• Glucagon-like Peptide-2.

  2006cites this paper
• Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.

  2006cites this paper
• Correlation between plasma glucagon-like peptide 2 levels and proliferative makers in small intestinal injury in rats induced by methotrexate administration.

  2006cites this paper
• Glucagon-like Peptide 2 Stimulates Intestinal Nutrient Absorption in Parenterally Fed Newborn Pigs

  2006cites this paper
• CHAPTER 6 – Gastrointestinal Peptide Hormones Regulating Energy and Glucose Homeostasis

  2006cites this paper
• Short-chain fatty acids impact on intestinal adaptation, inflammation, carcinoma, and failure.

  2006cites this paper
• Gut hormones ghrelin, PYY, and GLP-1 in the regulation of energy balance [corrected] and metabolism.

  2006cites this paper
• Glucagon and glucagon-like peptide receptors as drug targets.

  2006cites this paper
• Insulin-like growth factor-I (IGF-I) attenuates jejunal atrophy in association with increased expression of IGF-I binding protein-5 in parenterally fed mice.

  2005cites this paper
• Glucagon-like Peptide-2 (GLP-2) Response to Enteral Intake in Children During Anti-Cancer Treatment

  2005cites this paper
• Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets.

  2005cites this paper
• Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice.

  2005cites this paper
• Tales beyond the crypt: glucagon-like peptide-2 and cytoprotection in the intestinal mucosa.

  2005cites this paper
• Glucagon-like peptide 2: an update

  2005cites this paper
• Intestinal growth in parenterally-fed rats induced by the combined effects of glucagon-like peptide 2 and epidermal growth factor.

  2005cites this paper
• GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors.

  2005cites this paper
• Intestinal adaptation after massive intestinal resection

  2005cites this paper
• Glucagon-like peptide-1 and glucagon-like peptide-2

  2004cites this paper
• Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.

  2004influential citation
• Increased expression of specific intestinal amino acid and peptide transporter mRNA in rats fed by TPN is reversed by GLP-2.

  2004cites this paper
• Characterization of Two Novel Proabsorptive Peptide YY Analogs, BIM-43073D and BIM-43004C

  2004cites this paper
• Effect of Glucagon-like Peptide-2 (GLP-2) on Diurnal SGLT1 Expression

  2004cites this paper
• Glucagon-like peptide 2 (GLP-2), an intestinotrophic mediator.

  2004cites this paper
• Glucagon-like peptide-2: divergent signaling pathways.

  2004cites this paper
• Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.

  2004cites this paper
• Teduglutide ([Gly2]GLP‐2) protects small intestinal stem cells from radiation damage

  2004cites this paper
• The combination of metformin and a dipeptidyl peptidase IV inhibitor prevents 5-fluorouracil-induced reduction of small intestine weight.

  2004cites this paper
• Symposium: Glucagon-Like Peptide 2: Function and Clinical Applications

  2003cites this paper
• Effect of Minimal Enteral Feeding on Splanchnic Uptake of Leucine in the Postabsorptive State in Preterm Infants

  2003cites this paper
• Intestinal barrier: An interface between health and disease

  2003cites this paper
• Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis.

  2003cites this paper
• GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets 1.

  2003cites this paper
• Role of the Gut in the Course of Severe Acute Pancreatitis

  2003cites this paper
• Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa.

  2003cites this paper
• International Union of Pharmacology. XXXV. The Glucagon Receptor Family

  2003cites this paper
• Glucagon-like peptide-2-enhanced barrier function reduces pathophysiology in a model of food allergy.

  2003cites this paper
• Glucagon-like peptide 2 function in domestic animals.

  2003cites this paper
• Role of luminal nutrients and endogenous GLP-2 in intestinal adaptation to mid-small bowel resection.

  2003cites this paper
• Dual regulation of cell proliferation and survival via activation of glucagon-like peptide-2 receptor signaling.

  2003cites this paper
• Glucagon-Like Peptide 2 Enhances Maltase-Glucoamylase and Sucrase-Isomaltase Gene Expression and Activity in Parenterally Fed Premature Neonatal Piglets

  2002cites this paper
• Biological actions and therapeutic potential of the glucagon-like peptides.

  2002cites this paper
• The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist.

  2002cites this paper